Latest filing published 14 Jun 2024 for Aerovate Therapeutics, Inc., €144k. Read the official filing
This profile gathers the share dealings of Marinus Verwijs in Jade Biosciences, Inc. In total, 7 filings cover trades dated from 2 November 2022 to 14 June 2024.
The open-market record consists of 4 sales worth €84k, with no purchase. Outside the open market, there are 3 option exercises. So far in 2024, the count stands at no purchases and 1 sale.
The newest entry dates from 14 June 2024: an option exercise of €144k, in Jade Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations